Researchers at NYU School of Medicine have found that elevated cerebrospinal fluid levels of phosphorylated tau231, a damaged tau protein found in patients with Alzheimer's disease, may be an early diagnostic biomarker for Alzheimer's disease in healthy adults.
Feb 23, 2010 12:00 AM
—
www.eurekalert.org